# US 6,730,787 B1 · 2,4Dioxo-5-arylidenimino-1,3-pyrimidines

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,787 B1
- Document ID: US6730787B1
- Status: Granted
- Kind: B1
- Application number: 09/869,792
- Filed: 2001-07-02
- Granted: 2004-05-04
- Earliest claimed: 2001-07-02
- Assignees: Viromax, LLC
- Inventors: Viktor I. Krutikov; Rimma I. Ashkinazi
- Web page: https://patentgrep.com/patent/US6730787B1

## CPC

- C07D 239/545: with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- A61P 25/24: Antidepressants
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/12: Antivirals
- A61P 37/00: Drugs for immunological or allergic disorders
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to medicine, and more specifically to pharmacology, and in particular to synthetic biologically active derivatives of pyrimidine, and it is designated mainly for use as antiviral, immune-stimulating, antichlamydial, antituberculous, psychodepressant, analgesic, and hepatoprotective remedies. Besides that, these compounds may be used for treating malignant neoplasms, and also in veterinary. The objective of the invention is obtaining new chemical substances possessing pronounced biological activity of wide range. The proposed objective is achieved by synthesis of 2,4-dioxo-5-arylidenimino-1,3-pyrimidines of the general formula where R is chosen out of group H, OH, alkoxyl, dialkylamino, benzo, dibenzo, or 3,4-dioxolano General method of producing the claimed compounds and example of synthesis, a list of 25 compounds synthesized and tested, results of identification, and data on wide comparative testing their biological properties and toxicity are presented.

## Claims

### Claim 1

A 2.4-dioxo-5-arylidenimino-1,3-pyrimidine of the formula:
where n=1-3 and R is selected from the group consisting of hydroxyl, halogen, nitro, dialkylamino, dibenzo, and 3,4-dioxolano, with proviso that R is not hydroxyl and chloro at the same time, in any one molecule.

### Claim 2 (depends on 1)

A compound of claim 1, wherein R is 4-Cl.

### Claim 3 (depends on 1)

A compound of claim 1, wherein R is 3-Cl.

### Claim 4 (depends on 1)

A compound of claim 1, wherein R is 2-Cl.

### Claim 5 (depends on 1)

A compound of claim 1, wherein R is 4-Br.

### Claim 6 (depends on 1)

A compound of claim 1, wherein R is 4-OH.

### Claim 7 (depends on 1)

A compound of claim 1, wherein R is 2-OH-5-Br.

### Claim 8 (depends on 1)

A compound of claim 1, wherein R is 2-OH-5-Br.

### Claim 9 (depends on 1)

A compound of claim 1, wherein R is 4-F.

### Claim 10 (depends on 1)

A compound of claim 1, wherein R is 2,4-Cl2.

### Claim 11 (depends on 1)

A compound of claim 1, wherein R is 2-OH-3,5-Br2.

### Claim 12 (depends on 1)

A compound of claim 1, wherein R is 4-NO2.

### Claim 13 (depends on 1)

A compound of claim 1, wherein R is 3-NO2.

### Claim 14 (depends on 1)

A compound of claim 1, wherein R is 2-NO2.

### Claim 15 (depends on 1)

A compound of claim 1, wherein R is 2-OH-5-NO2.

### Claim 16 (depends on 1)

A compound of claim 1, wherein R is 3,4-dioxolano.

### Claim 17 (depends on 1)

A compound of claim 1, wherein R is 2-NO2-4,5 dioxolano.

### Claim 18 (depends on 1)

A compound of claim 1, wherein R is 2,3,5,6-dibenzo.

### Claim 19 (depends on 1)

A compound of claim 1, wherein R is 2-OH-3,5-I2.

### Claim 20 (depends on 1)

A compound of claim 1, wherein R is 4-N(CH3)2.
